Large DNA microarray dataset publicly available
As the next phase of DTI's Measurements for Biotechnology (MfB) program to 2007 gets underway, a large DNA microarray dataset generated by an LGC-led consortium during the first phase is now freely available online at ArrayExpress, a public repository managed by the European Bioinformatics Institute (EBI).
The sharing of well-annotated data is a primary objective of the Microarray Gene Expression Data (MGED) Society and this repository is stored in accordance with MGED recommendations.
Since the mid-1990s, DNA microarray technology has developed into a major tool for the investigation of global gene expression for all aspects of human disease. The technology is currently being explored for its efficacy in genomic approaches to toxicology. As toxicity is still the major cause of failure in clinical trials, there is strong industry interest in improved models for predictive toxicology.
Dr Carole Foy of LGC's Bio-Molecular Innovation group said: "This dataset is a significant milestone from the MfB project, "Comparability of gene expression measurements,' completed in 2004.
"So that the performance of microarrays can be maximised, LGC is working with the EBI in the current MfB program on the project, "Toxicogenomics: Quality metrics for improving microarray based measurements,' under the new Gene Measurement theme," she added.
The dataset produced by the LGC-led consortium relates to four commercially available arrays that probe the human genome, with between 4,000 and 30,000 genes probed per array. LGC measured gene expression status on 24 replicate arrays for each manufacturer, comparing a brain sample to a universal reference sample. NPL then contributed to the subsequent data analysis and normalisation in which nearly 700 text files containing well over eight million rows of microarray data were created. The dataset can be accessed at www.ebi.ac.uk/arrayexpress.
A portable, easy-to-use, point-of-care diagnostic system for COVID-19 can deliver patients their...
Blood cancer patients at Melbourne's Epworth HealthCare and Peter MacCallum Cancer Centre now...
A new viral diagnostic strategy using reactive polymer-grafted, double-stranded RNAs is expected...